Inhibikase Therapeutics, Inc. (IKT) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $181.20M | +83.8% |
| 2024 | $98.60M | +579.7% |
| 2023 | $14.51M | -41.8% |
| 2022 | $24.94M | -41.3% |
| 2021 | $42.47M | +187.3% |
| 2020 | $14.78M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $181.20M | +83.8% |
| 2024 | $98.60M | +579.7% |
| 2023 | $14.51M | -41.8% |
| 2022 | $24.94M | -41.3% |
| 2021 | $42.47M | +187.3% |
| 2020 | $14.78M | — |